Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents - Concepedia

Concepedia

Publication | Closed Access

Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents

63

Citations

23

References

2015

Year

Rolando M. Viani, Carmelita Alvero, Terry Fenton, Edward P. Acosta, Rohan Hazra, Ellen Townley, Debra Steimers, Sherene Min, Andrew Wiznia

The Pediatric Infectious Disease Journal

Abstract

Dolutegravir achieved target PK exposures in adolescents. Dolutegravir was safe and well tolerated, providing good virologic efficacy through week 48.

References

	Year	Citations

Page 1